Tetrabenazine as antichorea therapy in Huntington disease: A randomized controlled trial [4]

Neurology

Volumn 68, Issue 10, 2007, Pages 797-

  Savani, Aman A ^a   Login, Ivan S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; TETRABENAZINE; ANTIPARKINSON AGENT;

CLINICAL TRIAL; CORPUS STRIATUM; DOPAMINE METABOLISM; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; HUNTINGTON CHOREA; HYPOPHYSIS; LETTER; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; CHOREA; CONTROLLED CLINICAL TRIAL; NOTE; RANDOMIZED CONTROLLED TRIAL;

ANTI-DYSKINESIA AGENTS; CHOREA; HUMANS; HUNTINGTON DISEASE; RANDOMIZED CONTROLLED TRIALS; TETRABENAZINE;

EID: 33947518538     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000259143.52138.5c     Document Type: Letter

References (0)